A Single-arm, Single-center Exploratory Study of the Safety and Effectiveness of High-intensity Focused Ultrasound Therapy Combined With REGOTORI for Metastatic Colorectal Cancer
Latest Information Update: 01 Apr 2021
At a glance
- Drugs Regorafenib (Primary) ; Toripalimab (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions
- 01 Apr 2021 New trial record